Holen Sie sich die Stockscreener-App
0.8281
1.76%
-0.0148
Handel nachbörslich:
.83
0.0019
+0.23%
Schlusskurs vom Vortag:
$0.8429
Offen:
$0.83
24-Stunden-Volumen:
42,167
Relative Volume:
0.18
Marktkapitalisierung:
$74.28M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-30.15M
KGV:
-0.91
EPS:
-0.91
Netto-Cashflow:
$-31.63M
1W Leistung:
-2.83%
1M Leistung:
+21.78%
6M Leistung:
-1.35%
1J Leistung:
-65.92%
1-Tages-Spanne:
$0.82
$0.8499
1-Wochen-Bereich:
$0.81
$0.89
52-Wochen-Spanne:
$0.49
$2.5899
Context Therapeutics Inc Stock (CNTX) Company Profile
Firmenname
Context Therapeutics Inc
Sektor
Branche
Telefon
267-225-7416
Adresse
2001 MARKET STREET, PHILADELPHIA
Vergleichen Sie CNTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNTX
Context Therapeutics Inc
|
0.8281 | 76.23M | 0 | -30.15M | -31.63M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Context Therapeutics Inc Stock (CNTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-21 | Eingeleitet | William Blair | Outperform |
| 2025-01-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-11-25 | Eingeleitet | D. Boral Capital | Buy |
| 2024-05-16 | Eingeleitet | Piper Sandler | Overweight |
Context Therapeutics Inc Aktie (CNTX) Neueste Nachrichten
Order flow analysis tools used on Context Therapeutics Inc.2025 Market Outlook & Weekly High Conviction Ideas - Newser
Analyzing drawdowns of Context Therapeutics Inc. with statistical toolsRecession Risk & Low Risk High Reward Ideas - Newser
Best data tools to analyze Context Therapeutics Inc. stockQuarterly Trade Report & Step-by-Step Swing Trade Plans - Newser
Can Context Therapeutics Inc. stock outperform in a bear marketJuly 2025 Volume & Verified Chart Pattern Trade Signals - khodrobank.com
Measuring Context Therapeutics Inc.’s beta against major indices2025 Volume Leaders & Verified Momentum Stock Watchlist - Newser
Price action breakdown for Context Therapeutics Inc.Quarterly Trade Report & Trade Opportunity Analysis Reports - Newser
Market reaction to Context Therapeutics Inc.’s recent newsJuly 2025 Review & Accurate Intraday Trade Tips - Newser
Can momentum traders help lift Context Therapeutics Inc.Market Trend Report & Weekly Stock Breakout Alerts - Newser
Using Python tools to backtest Context Therapeutics Inc. strategies2025 Volatility Report & Safe Capital Growth Stock Tips - Newser
Does Context Therapeutics Inc. qualify in momentum factor screening2025 Institutional Moves & Weekly Top Performers Watchlists - Newser
Signal strength of Context Therapeutics Inc. stock in tech scannersJuly 2025 Sentiment & Free Reliable Trade Execution Plans - Newser
Earnings visualization tools for Context Therapeutics Inc.Short Setup & Accurate Buy Signal Alerts - Newser
Short interest data insights for Context Therapeutics Inc.Earnings Beat & Verified High Yield Trade Plans - Newser
Will Context Therapeutics Inc. rebound enough to break evenJuly 2025 Closing Moves & High Accuracy Trade Alerts - Newser
Context Therapeutics Inc. Inches Toward Key Resistance — Will It Break2025 Valuation Update & AI Forecast Swing Trade Picks - beatles.ru
News impact scoring models applied to Context Therapeutics Inc.Quarterly Profit Review & Daily Oversold Bounce Ideas - Newser
Context Therapeutics Granted Nasdaq Extension for Compliance - TipRanks
Is Context Therapeutics Inc. in a long term uptrendJuly 2025 Technicals & Daily Stock Trend Reports - khodrobank.com
Is Context Therapeutics Inc. forming a reversal patternWeekly Investment Summary & Safe Capital Growth Tips - Newser
Stock Recap: Is Context Therapeutics Inc. stock showing strong momentumJuly 2025 Volume & High Accuracy Investment Entry Signals - khodrobank.com
Can Context Therapeutics Inc. be the next market leaderJuly 2025 Weekly Recap & Free Weekly Watchlist of Top Performers - khodrobank.com
Is Context Therapeutics Inc. stock showing strong momentum2025 Top Gainers & Short-Term Trading Opportunity Alerts - khodrobank.com
How to forecast Context Therapeutics Inc. trends using time series2025 Analyst Calls & Capital Protection Trading Alerts - Newser
Is Context Therapeutics Inc. a play on infrastructure spendingMarket Sentiment Report & Verified Short-Term Plans - khodrobank.com
What is the PEG ratio of Context Therapeutics Inc.Weekly Profit Summary & Weekly Breakout Watchlists - خودرو بانک
Context Therapeutics Inc. Matches Institutional Buying Filter2025 Earnings Impact & Free AI Powered Buy and Sell Recommendations - beatles.ru
Applying sector rotation models to Context Therapeutics Inc.Earnings Miss & AI Forecast Swing Trade Picks - Newser
Top chart patterns to watch in Context Therapeutics Inc.Global Markets & Daily Price Action Insights - Newser
Tools to monitor Context Therapeutics Inc. recovery probabilityWeekly Trade Report & Verified Stock Trade Ideas - Newser
Quantitative breakdown of Context Therapeutics Inc. recent moveJuly 2025 Breakouts & Detailed Earnings Play Strategies - Newser
Regression Model Predicts Rangebound Movement in Context Therapeutics Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Is Context Therapeutics (CNTX) a High-Risk, High-Reward Play in Biotech Innovation? - AInvest
Context Therapeutics Inc. Nearing Breakout Level After Bounce getLinesFromResByArray error: size == 0 - news-j.co.kr
Is Context Therapeutics Inc. likely to announce a buybackJuly 2025 Earnings & Weekly High Potential Stock Alerts - sundaytimes.kr
Finanzdaten der Context Therapeutics Inc-Aktie (CNTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Context Therapeutics Inc-Aktie (CNTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Levit Alex C. | Chief Legal Officer, Corp. Sec |
Jun 06 '25 |
Buy |
0.58 |
20,000 |
11,520 |
29,000 |
| Minai-Azary Jennifer Lynn | Chief Financial Officer |
Jun 06 '25 |
Buy |
0.64 |
40,010 |
25,486 |
80,010 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):